A novel founder CHEK2 mutation is associated with increased prostate cancer risk (Q47755538)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2004
edit
Language Label Description Also known as
English
A novel founder CHEK2 mutation is associated with increased prostate cancer risk
scientific article published in April 2004

    Statements

    A novel founder CHEK2 mutation is associated with increased prostate cancer risk (English)
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit